GFM
TYRA icon

GF Fund Management’s Tyra Biosciences TYRA Stock Holding History

GF Fund Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1K Sell
1,131
-67
-6% -$2.22K ﹤0.01% 434
2026
Q1 		$45.9K Buy
1,198
+150
+14% +$4.86K ﹤0.01% 409
2025
Q4 		$27.6K Sell
1,048
-99
-9% -$1.82K ﹤0.01% 474
2025
Q3 		$16K Sell
1,147
-149
-11% -$1.7K ﹤0.01% 517
2025
Q2 		$12.4K Hold
1,296
– – ﹤0.01% 543
2025
Q1 		$12.1K Buy
1,296
+233
+22% +$3.02K ﹤0.01% 539
2024
Q4 		$14.8K Buy
+1,063
New +$19.3K ﹤0.01% 499

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

GF Fund Management's TYRA Position: Q2 2026 in Review

GF Fund Management reduced its Tyra Biosciences (TYRA) stake by 5.6% in Q2 2026, selling an estimated $2.22K and leaving 1,131 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

GF Fund Management first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $45.9K in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • GF Fund Management held 1,131 shares of Tyra Biosciences worth $36.1K as of Q2 2026.
  • GF Fund Management sold 67 Tyra Biosciences shares in Q2 2026, an estimated $2.22K.
  • Tyra Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #434 holding.
  • GF Fund Management first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Tyra Biosciences position peaked at $45.9K in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.